More Doses of MS Drug Raise Risk of Brain Infection (HealthDay)

HealthDay - FRIDAY, Feb. 5 (HealthDay News) -- In the latest blow to the controversial multiple sclerosis drug Tysabri, the U.S. Food and Drug Administration on Friday announced that it was slapping a new warning on the drug's label.

Read more | Previous | Next